Top 7 Venture Capital Funds Investing in MedTech

Venture funds actively support startups working in the field of medicine and biotechnology, investing in innovative developments that can revolutionize diagnostics, disease treatment, and medical technologies.

Published 3 min read

Sofinnova Partners
A leading European venture capital firm founded in 1972, specializing in life sciences with a focus on healthcare and sustainability. Sofinnova Partners manages over €2.8 billion in assets and has supported more than 500 companies over 50 years, creating global leaders across various industries. One notable investment is CorWave, which develops innovative devices for treating heart failure based on a unique wave membrane technology.

Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation was founded in 1973 as the venture capital arm of Johnson & Johnson. JJDC invests in startups and companies operating in pharmaceuticals, biotechnology, medical devices, diagnostics, and consumer products. Among its portfolio companies are Actelion Pharmaceuticals, specializing in biopharmaceuticals and cardiovascular disease treatment, and PathAI, which uses artificial intelligence for image-based disease diagnosis.

Frazier Healthcare Partners
Founded in 1991, the firm manages over $11 billion in assets and has invested in more than 200 companies in the United States, Canada, and Europe. Frazier Healthcare Partners focuses on investments in biopharmaceutical companies, medical devices, diagnostic tools, and healthcare service providers. Portfolio companies include Abode Healthcare, Accuity Delivery Systems, and Adare Pharma Solutions.

OrbiMed Advisors
A leading investment firm specializing in healthcare. In 1998, following the split of Mehta & Isaly, Samuel Isaly founded OrbiMed Advisors. OrbiMed manages approximately $18 billion in assets, investing in biopharmaceuticals, medical technology, diagnostic tools, and healthcare IT companies. OrbiMed’s portfolio includes more than 100 companies, such as Edgewise Therapeutics, Sinovac Biotech, Eli Lilly and Co, Boston Scientific, and Intuitive Surgical.

Versant Ventures
Versant Ventures is a venture capital firm founded in 1999 by partners from Brentwood Associates, Institutional Venture Partners, and Crosspoint Ventures. It specializes in healthcare and biotechnology investments, managing $5.5 billion in assets. The portfolio includes more than 50 IPOs and 50 mergers. Notable portfolio companies include BlueRock Therapeutics, HeartFlow (non-invasive heart diagnostics), and Inari Medical (devices for treating thrombosis). Versant Ventures’ investments range from $10 million to $50 million.

5AM Ventures
A venture capital firm founded in 2002 by John Dickman and Andrew Schwab. The firm specializes in investments in biopharmaceutical companies, drug delivery technologies, and life sciences research tools. Currently, 5AM Ventures manages two funds: 5AM Ventures VII, with a size of $450 million, and 5AM Opportunities II, with a size of $300 million. Portfolio companies include Achaogen, which develops antibiotics to combat infections.

Hercules Capital
Hercules Capital was founded in 2003. It is a leading provider of venture debt for innovative entrepreneurs and their venture partners. The company invests in technology, life sciences, SaaS and financial services, sustainable and renewable solutions, and special situations. Since its founding, Hercules Capital has supported more than 670 companies, including well-known names such as 23andMe, 908 Devices, and Acacia Pharma.